Skip to main content
All lobbying filings

The Procter and Gamble Company

The Procter and Gamble Company filed a Q1 report for The Procter and Gamble Company on April 22, 2025.

Lobbying for The Procter and Gamble Company

As filed: THE PROCTER AND GAMBLE COMPANY for THE PROCTER AND GAMBLE COMPANY.

All filings by The Procter and Gamble Company · Everything The Procter and Gamble Company has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 22, 2025
Expenses
$993,000
What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 13

-Issues related to immigration policy

-Issues related to new chemical approvals (no bill) -Implementation of Cybersecurity Reporting Law

-Issues related to East Coast/Gulf Coast Port Strike -Issues related to federal transportation supply chain & warehousing

-Issues related to artificial intelligence

-Data Privacy Legislation (No Bill)

-Issues related to labor and employment policy

-Issues related to U.S. Manufacturing

-OECD Digital Tax Project (Global Minimum Tax Implementation) -US Corporate and International Tax Reform (no bill) -OECD Digital Tax Project (Pillar One) -Taxation of Health Benefit Plans (No Bill)

-Issues related to plastic recycling -Issues related to new chemical approvals

-American First Trade Policy Executive Order -Executive Orders for IEEPA Tariffs -Issues related to the Trade Policy Act Section 232 Investigation of Softwood Lumber

-Issues related to Asia-Pacific Economic Cooperation (APEC)

-Issues related to product safety

-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 8599, Oral Health Products Inclusion Act

 Bills named in this filing 1
  • H.R. 8599
    Oral Health Products Inclusion Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem